Project
Illumina Body Map 2
Navigation
Downloads
Results for ETS1
Z-value: 2.25
Motif logo
Transcription factors associated with ETS1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ETS1
|
ENSG00000134954.10 | ETS proto-oncogene 1, transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ETS1 | hg19_v2_chr11_-_128457446_128457461 | 0.67 | 2.5e-05 | Click! |
Activity profile of ETS1 motif
Sorted Z-values of ETS1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr16_-_30393752 | 11.38 |
ENST00000566517.1
ENST00000605106.1 |
SEPT1
SEPT1
|
septin 1 Uncharacterized protein |
| chr16_+_30484054 | 10.82 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr16_+_30483962 | 10.42 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr17_+_38673270 | 9.11 |
ENST00000578280.1
|
RP5-1028K7.2
|
RP5-1028K7.2 |
| chr14_+_22475742 | 8.96 |
ENST00000390447.3
|
TRAV19
|
T cell receptor alpha variable 19 |
| chr11_+_67171391 | 8.63 |
ENST00000312390.5
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr11_+_67171548 | 8.52 |
ENST00000542590.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr1_-_161039456 | 8.46 |
ENST00000368016.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr16_+_30484021 | 8.34 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr11_+_67171358 | 8.33 |
ENST00000526387.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr1_-_167487808 | 8.32 |
ENST00000392122.3
|
CD247
|
CD247 molecule |
| chr1_-_167487758 | 8.26 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
| chr17_-_61776522 | 8.21 |
ENST00000582055.1
|
LIMD2
|
LIM domain containing 2 |
| chr17_-_38721711 | 8.18 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
| chr16_-_30394143 | 8.05 |
ENST00000321367.3
ENST00000571393.1 |
SEPT1
|
septin 1 |
| chr17_-_61777090 | 7.76 |
ENST00000578061.1
|
LIMD2
|
LIM domain containing 2 |
| chr19_+_42381173 | 7.09 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr11_-_118122996 | 7.06 |
ENST00000525386.1
ENST00000527472.1 ENST00000278949.4 |
MPZL3
|
myelin protein zero-like 3 |
| chr19_+_42381337 | 7.04 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr7_-_45018686 | 7.00 |
ENST00000258787.7
|
MYO1G
|
myosin IG |
| chr2_+_182321925 | 6.95 |
ENST00000339307.4
ENST00000397033.2 |
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
| chr15_+_81589254 | 6.82 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
| chr1_+_32739714 | 6.62 |
ENST00000461712.2
ENST00000373562.3 ENST00000477031.2 ENST00000373557.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr1_+_32739733 | 6.62 |
ENST00000333070.4
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr11_+_60223312 | 6.61 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr21_-_46340770 | 6.60 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr1_+_32716840 | 6.50 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr1_+_32716857 | 6.49 |
ENST00000482949.1
ENST00000495610.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr22_-_37545972 | 6.44 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
| chr1_+_203734296 | 6.40 |
ENST00000442561.2
ENST00000367217.5 |
LAX1
|
lymphocyte transmembrane adaptor 1 |
| chr5_+_133451254 | 6.37 |
ENST00000517851.1
ENST00000521639.1 ENST00000522375.1 ENST00000378560.4 ENST00000432532.2 ENST00000520958.1 ENST00000518915.1 ENST00000395023.1 |
TCF7
|
transcription factor 7 (T-cell specific, HMG-box) |
| chr2_+_204801471 | 6.34 |
ENST00000316386.6
ENST00000435193.1 |
ICOS
|
inducible T-cell co-stimulator |
| chr6_-_32160622 | 6.27 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
| chr7_+_106505912 | 6.26 |
ENST00000359195.3
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
| chr19_-_10450287 | 6.23 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
| chr6_-_31560729 | 6.11 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
| chr7_-_3083573 | 6.10 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
| chr17_+_4336955 | 6.10 |
ENST00000355530.2
|
SPNS3
|
spinster homolog 3 (Drosophila) |
| chr11_-_118083600 | 6.09 |
ENST00000524477.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
| chr9_-_71161505 | 6.06 |
ENST00000446290.1
|
RP11-274B18.2
|
RP11-274B18.2 |
| chr9_-_117150243 | 6.06 |
ENST00000374088.3
|
AKNA
|
AT-hook transcription factor |
| chr1_-_161039647 | 6.06 |
ENST00000368013.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr3_+_108541545 | 6.00 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr11_+_60223225 | 5.99 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr7_+_50348268 | 5.99 |
ENST00000438033.1
ENST00000439701.1 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
| chr7_+_106505696 | 5.89 |
ENST00000440650.2
ENST00000496166.1 ENST00000473541.1 |
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
| chr3_+_108541608 | 5.87 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr17_+_43299156 | 5.77 |
ENST00000331495.3
|
FMNL1
|
formin-like 1 |
| chr16_-_29757272 | 5.72 |
ENST00000329410.3
|
C16orf54
|
chromosome 16 open reading frame 54 |
| chr8_-_126963387 | 5.72 |
ENST00000522865.1
ENST00000517869.1 |
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr19_+_1077393 | 5.71 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr1_-_207095212 | 5.64 |
ENST00000420007.2
|
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr12_-_9760482 | 5.61 |
ENST00000229402.3
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1 |
| chr1_-_111743285 | 5.57 |
ENST00000357640.4
|
DENND2D
|
DENN/MADD domain containing 2D |
| chr10_+_49892904 | 5.56 |
ENST00000360890.2
|
WDFY4
|
WDFY family member 4 |
| chr2_+_218994002 | 5.52 |
ENST00000428565.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
| chr10_-_72362515 | 5.47 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
| chr22_+_44577237 | 5.42 |
ENST00000415224.1
ENST00000417767.1 |
PARVG
|
parvin, gamma |
| chrX_+_135730297 | 5.42 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
| chr20_-_1638408 | 5.38 |
ENST00000303415.3
ENST00000381583.2 |
SIRPG
|
signal-regulatory protein gamma |
| chr1_-_183559693 | 5.33 |
ENST00000367535.3
ENST00000413720.1 ENST00000418089.1 |
NCF2
|
neutrophil cytosolic factor 2 |
| chrX_-_70838306 | 5.30 |
ENST00000373691.4
ENST00000373693.3 |
CXCR3
|
chemokine (C-X-C motif) receptor 3 |
| chr17_+_43299241 | 5.26 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
| chr7_-_3083472 | 5.25 |
ENST00000356408.3
|
CARD11
|
caspase recruitment domain family, member 11 |
| chr12_-_57871853 | 5.25 |
ENST00000549602.1
ENST00000430041.2 |
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr12_-_57871825 | 5.24 |
ENST00000548139.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr3_-_183273477 | 5.24 |
ENST00000341319.3
|
KLHL6
|
kelch-like family member 6 |
| chr17_+_4337199 | 5.23 |
ENST00000333476.2
|
SPNS3
|
spinster homolog 3 (Drosophila) |
| chr12_-_57871620 | 5.22 |
ENST00000552604.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr13_-_46756351 | 5.20 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr12_-_57871567 | 5.18 |
ENST00000551452.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr20_+_24929866 | 5.18 |
ENST00000480798.1
ENST00000376835.2 |
CST7
|
cystatin F (leukocystatin) |
| chr1_+_153330322 | 5.18 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
| chr16_+_28996114 | 5.15 |
ENST00000395461.3
|
LAT
|
linker for activation of T cells |
| chr19_+_36393367 | 5.12 |
ENST00000246551.4
|
HCST
|
hematopoietic cell signal transducer |
| chr1_-_25256368 | 5.11 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
| chr6_-_159466136 | 5.10 |
ENST00000367066.3
ENST00000326965.6 |
TAGAP
|
T-cell activation RhoGTPase activating protein |
| chr20_-_1638360 | 5.09 |
ENST00000216927.4
ENST00000344103.4 |
SIRPG
|
signal-regulatory protein gamma |
| chrX_+_135730373 | 5.08 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
| chr8_-_133772794 | 5.05 |
ENST00000519187.1
ENST00000523829.1 ENST00000356838.3 ENST00000377901.4 ENST00000519304.1 |
TMEM71
|
transmembrane protein 71 |
| chr4_+_68424434 | 5.05 |
ENST00000265404.2
ENST00000396225.1 |
STAP1
|
signal transducing adaptor family member 1 |
| chr1_-_183560011 | 4.95 |
ENST00000367536.1
|
NCF2
|
neutrophil cytosolic factor 2 |
| chr12_-_53601055 | 4.94 |
ENST00000552972.1
ENST00000422257.3 ENST00000267082.5 |
ITGB7
|
integrin, beta 7 |
| chr1_-_207095324 | 4.92 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr9_-_137809718 | 4.91 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
| chr17_+_7239904 | 4.91 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr9_-_117150303 | 4.89 |
ENST00000312033.3
|
AKNA
|
AT-hook transcription factor |
| chr17_-_29641104 | 4.87 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
| chr4_-_109089573 | 4.86 |
ENST00000265165.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
| chr12_-_53601000 | 4.84 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
| chr17_-_29641084 | 4.83 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
| chr4_-_109088940 | 4.83 |
ENST00000438313.2
|
LEF1
|
lymphoid enhancer-binding factor 1 |
| chr2_+_69001913 | 4.76 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
| chr2_+_69002052 | 4.75 |
ENST00000497079.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
| chr16_+_28996416 | 4.74 |
ENST00000395456.2
ENST00000454369.2 |
LAT
|
linker for activation of T cells |
| chr16_+_29674277 | 4.73 |
ENST00000395389.2
|
SPN
|
sialophorin |
| chr12_+_7055767 | 4.73 |
ENST00000447931.2
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
| chr12_+_7055631 | 4.69 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
| chr19_+_17862274 | 4.67 |
ENST00000596536.1
ENST00000593870.1 ENST00000598086.1 ENST00000598932.1 ENST00000595023.1 ENST00000594068.1 ENST00000596507.1 ENST00000595033.1 ENST00000597718.1 |
FCHO1
|
FCH domain only 1 |
| chr8_-_126963417 | 4.67 |
ENST00000500989.2
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr8_-_126963487 | 4.66 |
ENST00000518964.1
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr6_-_159466042 | 4.60 |
ENST00000338313.5
|
TAGAP
|
T-cell activation RhoGTPase activating protein |
| chr17_+_4618734 | 4.59 |
ENST00000571206.1
|
ARRB2
|
arrestin, beta 2 |
| chr16_+_28996572 | 4.56 |
ENST00000360872.5
ENST00000566177.1 ENST00000354453.4 |
LAT
|
linker for activation of T cells |
| chr1_-_161039753 | 4.56 |
ENST00000368015.1
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr6_+_31554779 | 4.53 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
| chr8_-_133772870 | 4.51 |
ENST00000522334.1
ENST00000519016.1 |
TMEM71
|
transmembrane protein 71 |
| chr16_+_28996364 | 4.51 |
ENST00000564277.1
|
LAT
|
linker for activation of T cells |
| chr12_-_51717875 | 4.50 |
ENST00000604560.1
|
BIN2
|
bridging integrator 2 |
| chr5_+_35856951 | 4.49 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
| chr15_-_40600111 | 4.46 |
ENST00000543785.2
ENST00000260402.3 |
PLCB2
|
phospholipase C, beta 2 |
| chr15_-_40600026 | 4.43 |
ENST00000456256.2
ENST00000557821.1 |
PLCB2
|
phospholipase C, beta 2 |
| chr11_-_67205538 | 4.43 |
ENST00000326294.3
|
PTPRCAP
|
protein tyrosine phosphatase, receptor type, C-associated protein |
| chrX_-_70331298 | 4.43 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
| chr15_+_75074385 | 4.39 |
ENST00000220003.9
|
CSK
|
c-src tyrosine kinase |
| chr1_+_198607801 | 4.38 |
ENST00000367379.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr12_-_57873329 | 4.38 |
ENST00000424809.2
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr12_-_51717948 | 4.37 |
ENST00000267012.4
|
BIN2
|
bridging integrator 2 |
| chr12_-_51717922 | 4.34 |
ENST00000452142.2
|
BIN2
|
bridging integrator 2 |
| chr12_-_57873631 | 4.33 |
ENST00000393791.3
ENST00000356411.2 ENST00000552249.1 |
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr20_+_43104541 | 4.32 |
ENST00000372906.2
ENST00000456317.1 |
TTPAL
|
tocopherol (alpha) transfer protein-like |
| chr2_-_198175495 | 4.32 |
ENST00000409153.1
ENST00000409919.1 ENST00000539527.1 |
ANKRD44
|
ankyrin repeat domain 44 |
| chr11_+_48002279 | 4.30 |
ENST00000534219.1
ENST00000527952.1 |
PTPRJ
|
protein tyrosine phosphatase, receptor type, J |
| chr21_-_46340807 | 4.27 |
ENST00000397846.3
ENST00000524251.1 ENST00000522688.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr19_+_7413835 | 4.26 |
ENST00000576789.1
|
CTB-133G6.1
|
CTB-133G6.1 |
| chr1_+_16767167 | 4.26 |
ENST00000337132.5
|
NECAP2
|
NECAP endocytosis associated 2 |
| chr15_+_75074410 | 4.25 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
| chr19_+_36393422 | 4.22 |
ENST00000437550.2
|
HCST
|
hematopoietic cell signal transducer |
| chr1_+_16767195 | 4.20 |
ENST00000504551.2
ENST00000457722.2 ENST00000406746.1 ENST00000443980.2 |
NECAP2
|
NECAP endocytosis associated 2 |
| chrX_+_128913906 | 4.20 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
| chr9_+_273038 | 4.14 |
ENST00000487230.1
ENST00000469391.1 |
DOCK8
|
dedicator of cytokinesis 8 |
| chr1_-_162381907 | 4.14 |
ENST00000367929.2
ENST00000359567.3 |
SH2D1B
|
SH2 domain containing 1B |
| chr4_-_48082192 | 4.12 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
| chr1_+_27669719 | 4.12 |
ENST00000473280.1
|
SYTL1
|
synaptotagmin-like 1 |
| chr17_-_76123101 | 4.11 |
ENST00000392467.3
|
TMC6
|
transmembrane channel-like 6 |
| chr14_+_52327109 | 4.10 |
ENST00000335281.4
|
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2 |
| chr20_+_43514315 | 4.10 |
ENST00000353703.4
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
| chr10_+_26727333 | 4.09 |
ENST00000356785.4
|
APBB1IP
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
| chr12_-_54867352 | 4.08 |
ENST00000305879.5
|
GTSF1
|
gametocyte specific factor 1 |
| chrX_+_48542168 | 4.07 |
ENST00000376701.4
|
WAS
|
Wiskott-Aldrich syndrome |
| chr1_+_198608146 | 4.04 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr20_+_62367989 | 4.04 |
ENST00000309546.3
|
LIME1
|
Lck interacting transmembrane adaptor 1 |
| chrX_-_153192211 | 4.03 |
ENST00000461052.1
ENST00000422091.1 |
ARHGAP4
|
Rho GTPase activating protein 4 |
| chr22_+_40342819 | 4.02 |
ENST00000407075.3
|
GRAP2
|
GRB2-related adaptor protein 2 |
| chr14_+_52327350 | 4.02 |
ENST00000555472.1
ENST00000556766.1 |
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2 |
| chr4_+_153021899 | 3.98 |
ENST00000509332.1
ENST00000504144.1 ENST00000499452.2 |
RP11-18H21.1
|
RP11-18H21.1 |
| chr15_+_75074915 | 3.93 |
ENST00000567123.1
ENST00000569462.1 |
CSK
|
c-src tyrosine kinase |
| chr1_-_156786634 | 3.91 |
ENST00000392306.2
ENST00000368199.3 |
SH2D2A
|
SH2 domain containing 2A |
| chr21_-_46340884 | 3.89 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr19_-_10450328 | 3.88 |
ENST00000160262.5
|
ICAM3
|
intercellular adhesion molecule 3 |
| chr6_+_31553901 | 3.87 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
| chr1_+_198608292 | 3.87 |
ENST00000418674.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr4_-_39033963 | 3.86 |
ENST00000381938.3
|
TMEM156
|
transmembrane protein 156 |
| chr17_-_37934466 | 3.83 |
ENST00000583368.1
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
| chr14_-_23299009 | 3.82 |
ENST00000488800.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr22_-_29784519 | 3.82 |
ENST00000357586.2
ENST00000356015.2 ENST00000432560.2 ENST00000317368.7 |
AP1B1
|
adaptor-related protein complex 1, beta 1 subunit |
| chr19_+_55417530 | 3.80 |
ENST00000350790.5
ENST00000338835.5 ENST00000357397.5 |
NCR1
|
natural cytotoxicity triggering receptor 1 |
| chr6_+_31554612 | 3.80 |
ENST00000211921.7
|
LST1
|
leukocyte specific transcript 1 |
| chr22_+_44577724 | 3.79 |
ENST00000466375.2
|
PARVG
|
parvin, gamma |
| chr1_-_156786530 | 3.79 |
ENST00000368198.3
|
SH2D2A
|
SH2 domain containing 2A |
| chrX_-_153775760 | 3.75 |
ENST00000440967.1
ENST00000393564.2 ENST00000369620.2 |
G6PD
|
glucose-6-phosphate dehydrogenase |
| chrX_-_153775426 | 3.74 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr19_-_39826639 | 3.74 |
ENST00000602185.1
ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG
|
glia maturation factor, gamma |
| chr20_+_43514320 | 3.73 |
ENST00000372839.3
ENST00000428262.1 ENST00000445830.1 |
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
| chr19_+_49838653 | 3.72 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
| chr2_-_235405168 | 3.71 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr2_-_225811747 | 3.71 |
ENST00000409592.3
|
DOCK10
|
dedicator of cytokinesis 10 |
| chr6_+_31554826 | 3.71 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
| chr19_+_35940486 | 3.70 |
ENST00000246549.2
|
FFAR2
|
free fatty acid receptor 2 |
| chr6_+_31553978 | 3.69 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
| chr17_+_76126842 | 3.68 |
ENST00000590426.1
ENST00000590799.1 ENST00000318430.5 ENST00000589691.1 |
TMC8
|
transmembrane channel-like 8 |
| chr6_+_31554456 | 3.67 |
ENST00000339530.4
|
LST1
|
leukocyte specific transcript 1 |
| chr19_-_36399149 | 3.66 |
ENST00000585901.2
ENST00000544690.2 ENST00000424586.3 ENST00000262629.4 ENST00000589517.1 |
TYROBP
|
TYRO protein tyrosine kinase binding protein |
| chr12_+_25205666 | 3.66 |
ENST00000547044.1
|
LRMP
|
lymphoid-restricted membrane protein |
| chr19_+_6772710 | 3.66 |
ENST00000304076.2
ENST00000602142.1 ENST00000596764.1 |
VAV1
|
vav 1 guanine nucleotide exchange factor |
| chr16_+_50300427 | 3.65 |
ENST00000394697.2
ENST00000566433.2 ENST00000538642.1 |
ADCY7
|
adenylate cyclase 7 |
| chr5_+_176784837 | 3.64 |
ENST00000408923.3
|
RGS14
|
regulator of G-protein signaling 14 |
| chr8_+_29953163 | 3.63 |
ENST00000518192.1
|
LEPROTL1
|
leptin receptor overlapping transcript-like 1 |
| chr13_+_108922228 | 3.60 |
ENST00000542136.1
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b |
| chr7_-_150329421 | 3.60 |
ENST00000493969.1
ENST00000328902.5 |
GIMAP6
|
GTPase, IMAP family member 6 |
| chr1_-_168513229 | 3.59 |
ENST00000367819.2
|
XCL2
|
chemokine (C motif) ligand 2 |
| chr14_-_23284675 | 3.59 |
ENST00000555959.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr12_+_75874580 | 3.55 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr16_-_50715239 | 3.54 |
ENST00000330943.4
ENST00000300590.3 |
SNX20
|
sorting nexin 20 |
| chr1_+_168545711 | 3.53 |
ENST00000367818.3
|
XCL1
|
chemokine (C motif) ligand 1 |
| chr1_-_202129704 | 3.53 |
ENST00000476061.1
ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
| chr5_+_118668846 | 3.53 |
ENST00000513374.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr5_+_156693159 | 3.50 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr17_-_3867585 | 3.48 |
ENST00000359983.3
ENST00000352011.3 ENST00000397043.3 ENST00000397041.3 ENST00000397035.3 ENST00000397039.1 ENST00000309890.7 |
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous |
| chr12_-_6740802 | 3.45 |
ENST00000431922.1
|
LPAR5
|
lysophosphatidic acid receptor 5 |
| chr22_+_37257015 | 3.45 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
| chr19_-_4302375 | 3.44 |
ENST00000600114.1
ENST00000600349.1 ENST00000595645.1 ENST00000301272.2 |
TMIGD2
|
transmembrane and immunoglobulin domain containing 2 |
| chr14_+_105391147 | 3.44 |
ENST00000540372.1
ENST00000392593.4 |
PLD4
|
phospholipase D family, member 4 |
| chr1_-_150738261 | 3.40 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
| chr14_-_23284703 | 3.39 |
ENST00000555911.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr6_+_31554636 | 3.38 |
ENST00000433492.1
|
LST1
|
leukocyte specific transcript 1 |
| chr1_+_206730484 | 3.38 |
ENST00000304534.8
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5 |
| chr16_+_28505955 | 3.37 |
ENST00000564831.1
ENST00000328423.5 ENST00000431282.1 |
APOBR
|
apolipoprotein B receptor |
| chr21_-_15918618 | 3.37 |
ENST00000400564.1
ENST00000400566.1 |
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1 |
| chr16_-_88717482 | 3.37 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
Network of associatons between targets according to the STRING database.
First level regulatory network of ETS1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.5 | 10.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 3.3 | 16.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 2.9 | 2.9 | GO:1902214 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
| 2.9 | 8.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 2.6 | 7.9 | GO:1902227 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 2.5 | 24.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 2.5 | 12.3 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 2.2 | 6.5 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 2.1 | 12.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 2.0 | 6.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 2.0 | 12.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 1.8 | 39.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 1.8 | 12.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.8 | 17.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 1.8 | 33.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.7 | 6.9 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 1.7 | 5.1 | GO:0019085 | early viral transcription(GO:0019085) |
| 1.6 | 4.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.5 | 3.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 1.5 | 9.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.4 | 1.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 1.4 | 4.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.4 | 9.7 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.4 | 4.1 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 1.3 | 3.9 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 1.2 | 12.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.2 | 6.1 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.2 | 3.5 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.1 | 5.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.0 | 4.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 1.0 | 3.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
| 1.0 | 2.0 | GO:0042471 | ear morphogenesis(GO:0042471) |
| 1.0 | 4.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.9 | 6.6 | GO:2000330 | positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
| 0.9 | 2.8 | GO:0002339 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.9 | 0.9 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 0.9 | 5.5 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.9 | 4.6 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.9 | 6.4 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 0.9 | 3.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.9 | 4.5 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.9 | 7.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.9 | 7.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.9 | 10.3 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.9 | 0.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.8 | 3.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.8 | 4.1 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.8 | 0.8 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
| 0.8 | 4.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.8 | 2.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.8 | 2.4 | GO:0045556 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.8 | 3.8 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.7 | 5.2 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.7 | 3.7 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.7 | 5.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.7 | 2.9 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.7 | 14.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.7 | 11.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.7 | 5.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.7 | 3.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.7 | 2.1 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.7 | 3.4 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
| 0.7 | 2.0 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.7 | 3.3 | GO:0039516 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.6 | 1.9 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.6 | 1.3 | GO:0071336 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.6 | 4.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.6 | 12.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.6 | 2.5 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.6 | 14.8 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.6 | 3.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.6 | 1.8 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.6 | 1.8 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.6 | 1.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.6 | 1.8 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.6 | 2.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.6 | 4.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.6 | 4.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.6 | 5.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.6 | 1.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.6 | 1.7 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) mesenchymal cell development(GO:0014031) mesenchymal cell differentiation(GO:0048762) |
| 0.6 | 1.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.6 | 4.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.6 | 1.7 | GO:0061010 | external genitalia morphogenesis(GO:0035261) gall bladder development(GO:0061010) |
| 0.6 | 2.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.6 | 2.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.5 | 7.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.5 | 1.6 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
| 0.5 | 3.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.5 | 6.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.5 | 1.0 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.5 | 16.5 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.5 | 16.3 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.5 | 9.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.5 | 0.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.5 | 2.0 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.5 | 2.0 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.5 | 2.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.5 | 18.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.5 | 9.0 | GO:0002418 | immune response to tumor cell(GO:0002418) |
| 0.5 | 1.4 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.5 | 2.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.5 | 3.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.5 | 4.7 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.5 | 1.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.5 | 1.9 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.5 | 0.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.5 | 2.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.5 | 2.3 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.5 | 1.4 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 | 0.5 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.5 | 14.6 | GO:0002715 | regulation of natural killer cell mediated immunity(GO:0002715) |
| 0.5 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.5 | 3.2 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.4 | 2.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.4 | 1.3 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.4 | 27.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.4 | 3.9 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.4 | 10.8 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.4 | 6.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.4 | 1.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.4 | 3.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.4 | 3.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.4 | 2.0 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.4 | 1.6 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.4 | 3.7 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.4 | 2.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.4 | 2.8 | GO:1902564 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of neutrophil activation(GO:1902564) |
| 0.4 | 1.6 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.4 | 5.0 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.4 | 2.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.4 | 3.8 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.4 | 1.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.4 | 3.4 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.4 | 7.5 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.4 | 2.3 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.4 | 1.1 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.4 | 6.3 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.4 | 37.6 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.4 | 19.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.4 | 1.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.4 | 5.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
| 0.4 | 2.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.4 | 1.8 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.4 | 8.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 | 1.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.3 | 1.0 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 | 1.7 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 2.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.3 | 2.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.3 | 3.4 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.3 | 2.0 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 | 2.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 | 5.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.3 | 1.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.3 | 1.9 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.3 | 0.3 | GO:0031929 | TOR signaling(GO:0031929) |
| 0.3 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.3 | 3.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.3 | 4.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 4.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.3 | 3.9 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.3 | 1.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 | 8.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.3 | 1.1 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.3 | 5.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.3 | 0.6 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.3 | 5.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 4.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.3 | 4.5 | GO:0072678 | T cell migration(GO:0072678) |
| 0.3 | 10.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.3 | 1.6 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.3 | 0.8 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.3 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 | 1.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.3 | 1.0 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.3 | 8.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.3 | 5.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.3 | 1.0 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.3 | 2.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 0.7 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.2 | 17.7 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.2 | 0.5 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.2 | 0.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 | 1.7 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 1.7 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.2 | 3.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 | 1.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.2 | 0.7 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.2 | 2.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
| 0.2 | 7.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 | 2.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 | 0.9 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 | 1.2 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.2 | 1.4 | GO:0061470 | interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
| 0.2 | 0.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.2 | 2.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.2 | 1.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.2 | 13.0 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.2 | 2.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.2 | 6.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 6.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.2 | 1.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.2 | 3.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.2 | 1.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 0.4 | GO:0072641 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.2 | 4.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 | 0.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.2 | 0.6 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.2 | 0.8 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 | 2.0 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.2 | 1.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 | 1.6 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.2 | 0.8 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 0.2 | 2.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 | 4.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.2 | 3.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.2 | 5.7 | GO:0050798 | activated T cell proliferation(GO:0050798) |
| 0.2 | 1.9 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.2 | 0.9 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 | 0.6 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.2 | 0.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.2 | 4.8 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.2 | 0.6 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.2 | 0.4 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.2 | 0.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.2 | 0.9 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.2 | 3.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 | 2.7 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 2.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.2 | 3.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 | 1.7 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 3.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 | 1.4 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 | 7.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.2 | 1.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.2 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.2 | 1.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.2 | 0.5 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.2 | 1.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 5.4 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.2 | 1.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 | 2.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 | 6.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 0.3 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
| 0.2 | 1.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.2 | 0.6 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 | 1.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 | 1.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 1.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.2 | 3.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 1.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 | 1.7 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.2 | 0.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.2 | 0.8 | GO:2000078 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.2 | 0.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.2 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 0.9 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 3.4 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 2.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 1.8 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 0.1 | 5.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 | 0.6 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.1 | 2.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 | 3.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 2.0 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.1 | 0.5 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.1 | 1.3 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.1 | 0.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 | 1.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.1 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 | 1.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 1.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.1 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 1.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 20.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 1.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 1.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.1 | 2.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 2.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.6 | GO:0010182 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 | 0.4 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.1 | 4.2 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 | 0.5 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.1 | 3.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.1 | 0.9 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 4.5 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.1 | 1.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 2.2 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.9 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 | 0.5 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 | 0.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
| 0.1 | 9.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 | 1.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 3.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.9 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.1 | 0.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.1 | 0.8 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.1 | 0.4 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 3.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.1 | 0.4 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.1 | 1.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 0.7 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 0.8 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 2.7 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.6 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 11.3 | GO:0050870 | positive regulation of T cell activation(GO:0050870) |
| 0.1 | 1.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 72.8 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 1.0 | GO:1900044 | negative regulation of histone ubiquitination(GO:0033183) regulation of protein K63-linked ubiquitination(GO:1900044) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 | 0.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.1 | 1.0 | GO:0035745 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 | 0.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 0.3 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.1 | 1.4 | GO:0007568 | aging(GO:0007568) |
| 0.1 | 0.7 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.6 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 | 1.9 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 1.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 | 1.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.2 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.1 | 0.7 | GO:0046607 | positive regulation of mitotic centrosome separation(GO:0046604) positive regulation of centrosome cycle(GO:0046607) |
| 0.1 | 0.2 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.1 | 0.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 0.6 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 0.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 1.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.1 | 1.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 | 1.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.1 | 0.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 | 1.6 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 1.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 | 1.3 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.1 | 2.8 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
| 0.1 | 0.9 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 1.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.1 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.1 | 1.3 | GO:0090050 | peptidyl-lysine deacetylation(GO:0034983) positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 1.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 6.8 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.1 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 2.2 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.1 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 0.4 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.1 | 0.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 | 1.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 | 0.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 1.5 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 4.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.4 | GO:0015853 | adenine transport(GO:0015853) |
| 0.1 | 2.0 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.1 | 0.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 | 0.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 6.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 0.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 0.3 | GO:1903899 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 | 0.2 | GO:0021997 | neural plate axis specification(GO:0021997) |
| 0.1 | 7.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 3.8 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
| 0.1 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 1.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 1.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 3.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 5.4 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.1 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 1.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 | 3.4 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 1.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.1 | 0.3 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 2.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 | 0.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 0.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 2.1 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.1 | 0.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 1.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 2.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 3.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.1 | 2.5 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 2.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.1 | 0.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 1.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 3.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 1.0 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 2.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.1 | 1.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 | 0.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.1 | 1.1 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 1.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.1 | 4.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.1 | 0.3 | GO:2000329 | peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.0 | 0.4 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.0 | 0.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 | 1.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.0 | 1.4 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.0 | 4.5 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 0.2 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.0 | 2.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.0 | 4.0 | GO:0030282 | bone mineralization(GO:0030282) |
| 0.0 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.0 | 9.3 | GO:0007411 | axon guidance(GO:0007411) |
| 0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.0 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 1.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.0 | 0.7 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.0 | 0.4 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 | 1.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 1.3 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 0.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.0 | 1.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.0 | 0.1 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 | 0.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 | 1.9 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.0 | 5.7 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.0 | 1.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 | 6.4 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
| 0.0 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 | 0.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.8 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 31.1 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.0 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.0 | 1.8 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 1.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 | 1.0 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 | 3.1 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.0 | 0.3 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.0 | 1.2 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.0 | 5.1 | GO:0050776 | regulation of immune response(GO:0050776) |
| 0.0 | 1.0 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 1.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 | 0.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 0.4 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
| 0.0 | 0.5 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 1.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.4 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.0 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 1.9 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.0 | 1.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 | 1.9 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 0.3 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 | 0.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.0 | 0.5 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
| 0.0 | 1.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.0 | 0.8 | GO:0033198 | response to ATP(GO:0033198) |
| 0.0 | 0.2 | GO:2000114 | regulation of establishment or maintenance of cell polarity(GO:0032878) regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 | 0.2 | GO:1902230 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.0 | 0.3 | GO:0060039 | pericardium development(GO:0060039) |
| 0.0 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.5 | GO:0016246 | RNA interference(GO:0016246) |
| 0.0 | 0.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.8 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 | 0.5 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
| 0.0 | 0.3 | GO:0046686 | response to cadmium ion(GO:0046686) |
| 0.0 | 1.1 | GO:0006281 | DNA repair(GO:0006281) |
| 0.0 | 0.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 | 0.9 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.0 | 3.5 | GO:0006897 | endocytosis(GO:0006897) |
| 0.0 | 1.2 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
| 0.0 | 0.1 | GO:0090283 | negative regulation of protein glycosylation(GO:0060051) regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.0 | 0.8 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.0 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.0 | 0.3 | GO:0031497 | chromatin assembly(GO:0031497) |
| 0.0 | 0.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.0 | 0.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 | 0.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.0 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.4 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
| 0.0 | 0.5 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.0 | 0.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.0 | 1.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.0 | 1.0 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) |
| 0.0 | 0.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 | 0.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 | 1.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 0.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 1.4 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.0 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 | 0.8 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.2 | GO:0060325 | head morphogenesis(GO:0060323) face morphogenesis(GO:0060325) |
| 0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 0.4 | GO:1900180 | regulation of protein localization to nucleus(GO:1900180) |
| 0.0 | 0.0 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 | 1.6 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.0 | 0.2 | GO:0045471 | response to ethanol(GO:0045471) |
| 0.0 | 0.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.0 | 0.6 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.0 | 0.2 | GO:0046794 | transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
| 0.0 | 0.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 44.3 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 3.3 | 16.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 3.0 | 12.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 2.0 | 14.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 2.0 | 26.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 1.4 | 4.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 1.4 | 33.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.4 | 13.7 | GO:0032010 | phagolysosome(GO:0032010) |
| 1.3 | 4.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 1.3 | 3.9 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 1.1 | 3.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 1.1 | 3.2 | GO:0036398 | TCR signalosome(GO:0036398) |
| 1.0 | 4.1 | GO:0012506 | vesicle membrane(GO:0012506) |
| 0.9 | 5.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.9 | 58.1 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.8 | 4.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.8 | 5.5 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.8 | 24.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.7 | 3.7 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.7 | 4.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.7 | 9.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.7 | 4.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.7 | 14.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.6 | 1.9 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.6 | 3.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.6 | 1.8 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.6 | 12.1 | GO:0032059 | bleb(GO:0032059) |
| 0.6 | 4.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.6 | 2.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.5 | 24.5 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.5 | 9.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.5 | 4.0 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.5 | 2.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.5 | 3.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.5 | 1.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.5 | 3.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.5 | 3.2 | GO:0032009 | early phagosome(GO:0032009) |
| 0.4 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.4 | 1.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.4 | 2.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.4 | 1.6 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.4 | 3.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.4 | 6.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.4 | 2.6 | GO:0089701 | U2AF(GO:0089701) |
| 0.4 | 2.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.3 | 1.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.3 | 3.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.3 | 3.8 | GO:0016589 | NURF complex(GO:0016589) |
| 0.3 | 1.0 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.3 | 4.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.3 | 1.0 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.3 | 2.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.3 | 2.5 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.3 | 4.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 11.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.3 | 2.0 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 1.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.3 | 1.8 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.3 | 6.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.3 | 27.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.3 | 1.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.2 | 5.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 0.7 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.2 | 0.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 7.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.2 | 4.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 3.3 | GO:0097433 | dense body(GO:0097433) |
| 0.2 | 0.6 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.2 | 1.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.2 | 1.0 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.2 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.2 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.2 | 2.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.2 | 1.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.2 | 6.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 21.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.2 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.2 | 2.0 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.2 | 2.4 | GO:0031968 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
| 0.2 | 1.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.2 | 3.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.2 | 1.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.2 | 2.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.2 | 65.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.2 | 0.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
| 0.2 | 6.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 0.5 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.1 | 3.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.1 | 18.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.6 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.1 | 1.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 4.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 9.0 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 1.6 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 1.3 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.1 | 1.0 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 3.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 2.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 1.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 9.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 5.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 1.7 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.1 | 26.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.1 | 8.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 1.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 3.0 | GO:0042627 | chylomicron(GO:0042627) |
| 0.1 | 1.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 3.5 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 2.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.1 | 14.1 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 17.4 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 0.8 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 26.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.1 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 2.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 3.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 1.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 0.4 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 6.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 0.4 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.1 | 1.6 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 3.5 | GO:0031105 | septin complex(GO:0031105) |
| 0.1 | 0.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 2.2 | GO:0044440 | endosomal part(GO:0044440) |
| 0.1 | 1.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.9 | GO:0036452 | ESCRT complex(GO:0036452) |
| 0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 1.8 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 0.5 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 2.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 37.9 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.1 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 1.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 1.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 1.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 1.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.1 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 0.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 8.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 1.3 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 1.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 1.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 1.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 1.4 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.1 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.1 | 4.3 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 1.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 1.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 2.3 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.0 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 1.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.0 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 1.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.6 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
| 0.0 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 3.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.0 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.0 | 8.7 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 2.2 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.0 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 1.9 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.0 | 1.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 1.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 12.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 2.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 8.1 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.0 | 1.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.0 | 1.4 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.0 | 3.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 1.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 1.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.0 | 4.1 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 15.3 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 3.2 | GO:0005635 | nuclear envelope(GO:0005635) |
| 0.0 | 1.0 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.0 | 1.1 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 0.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 1.3 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.0 | 0.7 | GO:0030662 | ER to Golgi transport vesicle membrane(GO:0012507) coated vesicle membrane(GO:0030662) |
| 0.0 | 0.8 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 3.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.0 | 0.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 0.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.0 | 0.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 0.3 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.9 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.0 | 1.4 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.0 | 0.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 15.2 | GO:0005829 | cytosol(GO:0005829) |
| 0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 0.6 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 0.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 0.7 | GO:0043679 | axon terminus(GO:0043679) |
| 0.0 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.7 | 44.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 3.5 | 10.5 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 2.9 | 26.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 2.5 | 12.7 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 2.2 | 4.5 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 1.9 | 11.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 1.8 | 9.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 1.6 | 7.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.5 | 4.6 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 1.3 | 4.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 1.2 | 6.9 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 1.1 | 12.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 1.1 | 23.8 | GO:0005522 | profilin binding(GO:0005522) |
| 1.0 | 31.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 1.0 | 5.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 1.0 | 2.9 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 1.0 | 3.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.9 | 5.5 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 0.9 | 7.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.8 | 8.5 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.8 | 4.1 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.8 | 2.4 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.7 | 16.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.7 | 12.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.7 | 16.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.7 | 3.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.7 | 4.8 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.7 | 7.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.7 | 3.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.7 | 5.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.7 | 10.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.7 | 5.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.6 | 1.9 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.6 | 3.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.6 | 2.6 | GO:0019862 | IgA binding(GO:0019862) |
| 0.6 | 1.3 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.6 | 6.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.6 | 2.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.6 | 2.9 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.6 | 6.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.6 | 2.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.6 | 5.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.6 | 4.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.6 | 1.7 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.6 | 1.7 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.6 | 4.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.5 | 13.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.5 | 2.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.5 | 9.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.5 | 3.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.5 | 2.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.5 | 18.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.5 | 4.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.5 | 7.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.5 | 1.4 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.5 | 3.3 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.5 | 34.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.5 | 4.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.5 | 1.8 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) copper-dependent protein binding(GO:0032767) |
| 0.5 | 13.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.4 | 20.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.4 | 2.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.4 | 1.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.4 | 1.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.4 | 3.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.4 | 1.7 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.4 | 1.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.4 | 1.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.4 | 2.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.4 | 2.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.4 | 15.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.4 | 3.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.4 | 2.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.3 | 3.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.3 | 1.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.3 | 6.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 1.0 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.3 | 2.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.3 | 3.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.3 | 7.0 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.3 | 0.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.3 | 2.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.3 | 11.4 | GO:0023026 | MHC protein complex binding(GO:0023023) MHC class II protein complex binding(GO:0023026) |
| 0.3 | 1.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.3 | 1.6 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.3 | 10.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 0.9 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
| 0.3 | 3.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.3 | 2.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.3 | 7.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 2.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.3 | 2.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.3 | 9.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.3 | 0.8 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.3 | 2.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.3 | 1.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.2 | 1.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.2 | 1.9 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.2 | 1.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 5.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.2 | 4.3 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.2 | 0.9 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.2 | 7.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 9.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 2.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.2 | 1.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.2 | 31.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 0.6 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.2 | 1.0 | GO:0089720 | caspase binding(GO:0089720) |
| 0.2 | 8.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.2 | 0.8 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.2 | 2.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 2.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.2 | 0.6 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.2 | 7.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.2 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 1.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.2 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 0.9 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.2 | 3.0 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 1.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 0.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.2 | 8.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.2 | 1.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.2 | 5.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.2 | 3.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 0.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.2 | 1.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.2 | 1.1 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.2 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 0.6 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
| 0.2 | 0.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.2 | 1.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.2 | 0.5 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.2 | 0.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.2 | 1.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.2 | 0.9 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 6.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 2.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 3.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 1.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 4.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 73.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.4 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.1 | 0.4 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.1 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 2.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.1 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 2.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 5.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 2.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 1.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 1.5 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 3.9 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.4 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 0.1 | 3.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 3.7 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 5.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.1 | 3.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 2.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.1 | 1.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 1.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.1 | 0.4 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.1 | 3.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 3.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.1 | 0.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.1 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 1.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.1 | 1.6 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.1 | 1.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 1.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 1.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.1 | 3.1 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 0.3 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.1 | 0.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 1.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.3 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.1 | 0.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 1.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 0.7 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 0.6 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.1 | 0.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 1.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 2.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 1.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 1.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 2.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 14.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.1 | 0.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 2.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 3.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.1 | 1.9 | GO:0019955 | cytokine binding(GO:0019955) |
| 0.1 | 4.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 2.7 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 1.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 1.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
| 0.1 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 4.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 6.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.1 | 0.4 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.1 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.1 | 3.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 6.9 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 5.3 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 1.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.1 | 1.2 | GO:0019209 | kinase activator activity(GO:0019209) |
| 0.1 | 1.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 2.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 2.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 1.8 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 0.3 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 7.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 1.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 1.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 3.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 3.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.1 | 0.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 2.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 1.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 0.5 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 1.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 0.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 10.8 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 3.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.1 | 3.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.1 | 0.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 1.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 1.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 0.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 6.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.0 | 1.5 | GO:0032041 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.0 | 2.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 1.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.0 | 2.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.0 | 1.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.0 | 3.1 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.0 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.0 | 0.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.0 | 3.7 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.0 | 1.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 1.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 1.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 0.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.0 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.0 | 2.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.0 | 0.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 1.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.0 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 2.5 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 1.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.0 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 1.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.4 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.0 | 1.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.0 | 13.6 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
| 0.0 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 6.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.0 | 0.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 0.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.0 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 1.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 0.9 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
| 0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 2.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.0 | 1.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.0 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 0.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.0 | 0.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.0 | 6.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.0 | 0.9 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.0 | 1.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.0 | 0.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.0 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.9 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
| 0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 2.1 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.0 | 0.1 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.0 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.1 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 1.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.4 | GO:0032451 | demethylase activity(GO:0032451) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 142.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 1.0 | 70.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.9 | 35.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.6 | 8.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.5 | 14.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.4 | 14.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.4 | 6.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.3 | 18.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 22.9 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.3 | 8.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.3 | 16.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.3 | 13.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.3 | 31.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.3 | 41.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.3 | 23.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.3 | 2.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.3 | 11.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.3 | 10.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.3 | 22.0 | PID ATM PATHWAY | ATM pathway |
| 0.2 | 2.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 2.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.2 | 15.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.2 | 15.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.2 | 7.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 6.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.2 | 24.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 1.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.1 | 4.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 3.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 5.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 2.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 3.4 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 4.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 10.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 7.2 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 9.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 0.7 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 3.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 2.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 2.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 2.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 1.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 2.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 3.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 2.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 3.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 1.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 5.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 3.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 1.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 1.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 4.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 1.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 1.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.0 | 15.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 1.9 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 67.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 1.1 | 3.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.0 | 9.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.9 | 36.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.8 | 101.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.7 | 8.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.6 | 29.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.6 | 8.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.5 | 15.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.5 | 8.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.5 | 30.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.5 | 12.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.5 | 5.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.4 | 20.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.4 | 9.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.4 | 21.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.4 | 23.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.4 | 8.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.4 | 6.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.4 | 7.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.4 | 27.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.3 | 3.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.3 | 7.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.3 | 7.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.3 | 6.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.3 | 3.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.3 | 1.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.3 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.3 | 30.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.2 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.2 | 5.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 3.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.2 | 12.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.2 | 3.9 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.2 | 3.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 1.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.2 | 3.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 2.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.2 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.2 | 4.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 25.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 5.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 2.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 8.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.2 | 7.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.1 | 2.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.1 | 6.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 1.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 1.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 1.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 3.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 2.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.1 | 3.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 2.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 3.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 3.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 8.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 1.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 4.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 18.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 3.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 2.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 5.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 5.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 6.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.1 | 1.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 0.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.1 | 3.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.1 | 1.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.1 | 2.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.1 | 6.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 1.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 4.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 1.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 1.6 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.1 | 3.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.1 | 0.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 1.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 1.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 6.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.0 | 0.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.0 | 2.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 2.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 1.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 1.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 5.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 1.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 0.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 2.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 1.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 1.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 0.7 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |